MedTrace Logo

Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus

NCT06018844 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2025-08-19

Study results available
· View outcomes & findings →

Summary

The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D)

The main question\[s\] it aims to answer are:

* Does the intervention increase the amount of text messages between the mHealth software and participants?
* Do the text messages from the Nudge software increase moderate to vigorous physical activity (MVPA) in participants?
* Does the MVPA encouraged by the Nudge software improve the HbA1c levels of participants?

Participants will:

* Receive text messages from the Nudge software
* Report physical activity goals via the text messages to the Nudge software
* Wear both an accelerometer and an actigraph for three weeks (spread out across the beginning, 30 days, and 90 days of participation)
* Complete surveys at the beginning of participation
* Complete daily surveys while wearing the devices
* Complete surveys at the end of participation
* Record physical activity in study surveys

Conditions

Interventions

OTHER

NUDGE

NUDGE is a brief mHealth text messaging intervention designed to promote activity in adolescents by allowing them to set, monitor, and receive feedback on daily PA goals through text message.

Sponsors & Collaborators

  • University of Kansas

    collaborator OTHER

  • Nemours Children's Clinic

    collaborator OTHER

  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Mark Clements, MD · Children's Mercy

Eligibility

Min Age
13 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2025-06-26
Completion
2025-06-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018844 on ClinicalTrials.gov